PepGen Statistics
Total Valuation
PepGen has a market cap or net worth of $197.13 million. The enterprise value is $95.99 million.
| Market Cap | 197.13M |
| Enterprise Value | 95.99M |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PepGen has 69.17 million shares outstanding. The number of shares has increased by 85.07% in one year.
| Current Share Class | 69.17M |
| Shares Outstanding | 69.17M |
| Shares Change (YoY) | +85.07% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 36.66% |
| Float | 34.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.65 |
| P/TBV Ratio | 1.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.36, with a Debt / Equity ratio of 0.13.
| Current Ratio | 13.36 |
| Quick Ratio | 13.02 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -75.45% and return on invested capital (ROIC) is -42.42%.
| Return on Equity (ROE) | -75.45% |
| Return on Assets (ROA) | -39.12% |
| Return on Invested Capital (ROIC) | -42.42% |
| Return on Capital Employed (ROCE) | -57.59% |
| Weighted Average Cost of Capital (WACC) | 13.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.22M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PepGen has paid $80,000 in taxes.
| Income Tax | 80,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +108.03% in the last 52 weeks. The beta is 1.89, so PepGen's price volatility has been higher than the market average.
| Beta (5Y) | 1.89 |
| 52-Week Price Change | +108.03% |
| 50-Day Moving Average | 1.85 |
| 200-Day Moving Average | 3.82 |
| Relative Strength Index (RSI) | 74.16 |
| Average Volume (20 Days) | 1,173,543 |
Short Selling Information
The latest short interest is 4.53 million, so 6.55% of the outstanding shares have been sold short.
| Short Interest | 4.53M |
| Short Previous Month | 4.00M |
| Short % of Shares Out | 6.55% |
| Short % of Float | 13.34% |
| Short Ratio (days to cover) | 4.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -76.24M |
| Pretax Income | -71.86M |
| Net Income | -71.94M |
| EBITDA | -71.25M |
| EBIT | -76.24M |
| Earnings Per Share (EPS) | -$1.19 |
Balance Sheet
The company has $117.24 million in cash and $16.09 million in debt, with a net cash position of $101.15 million or $1.46 per share.
| Cash & Cash Equivalents | 117.24M |
| Total Debt | 16.09M |
| Net Cash | 101.15M |
| Net Cash Per Share | $1.46 |
| Equity (Book Value) | 119.53M |
| Book Value Per Share | 1.73 |
| Working Capital | 111.32M |
Cash Flow
In the last 12 months, operating cash flow was -$69.34 million and capital expenditures -$126,000, giving a free cash flow of -$69.46 million.
| Operating Cash Flow | -69.34M |
| Capital Expenditures | -126,000 |
| Depreciation & Amortization | 1.25M |
| Net Borrowing | n/a |
| Free Cash Flow | -69.46M |
| FCF Per Share | -$1.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PepGen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -85.07% |
| Shareholder Yield | -85.07% |
| Earnings Yield | -36.49% |
| FCF Yield | -35.24% |
Analyst Forecast
The average price target for PepGen is $11.29, which is 296.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.29 |
| Price Target Difference | 296.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |